Lexicon Pharmaceuticals to Present New Sotagliflozin Data on Adipose Distribution in Non-Diabetic HFpEF Patients
I'm PortAI, I can summarize articles.
Lexicon Pharmaceuticals will present new clinical data on sotagliflozin's effect on adipose tissue distribution in non-diabetic HFpEF patients at the CVCT 2025 forum in Washington, D.C. The data comes from the SOTA-P-CARDIA trial conducted by Mount Sinai Medical Center. The presentation by Juan Jose Badimon, Ph.D., is scheduled for December 8, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments